Dermatology NewsBiologic benefit in psoriasis might extend to arthritis preventionAugust 30, 2021Psoriatic ArthritisPsoriasis
Dermatology NewsBimekizumab approved in Europe for psoriasis treatmentAugust 25, 2021PsoriasisPsoriatic Arthritis
Dermatology NewsPsoriatic arthritis health care costs continue to rise over timeAugust 24, 2021Psoriatic ArthritisPsoriasis
Translating the 2019 AAD-NPF Guidelines of Care for Psoriasis With Attention to ComorbiditiesAugust 19, 2021PsoriasisPsoriatic Arthritis
Psoriatic Arthritis Diagnosis and Management in the Era of TelehealthAugust 19, 2021Psoriatic ArthritisPsoriasis
Dermatology NewsWestern diet promoted skin, joint inflammation in preclinical studyAugust 16, 2021PsoriasisPsoriatic Arthritis
Dermatology NewsPhysicians question the future of TNF inhibitors for psoriasis, PsAAugust 6, 2021Psoriatic ArthritisPsoriasis
Dermatology News‘Gold cards’ allow Texas docs to skip prior authorizationsJuly 16, 2021Business of MedicinePsoriasisPsoriatic ArthritisAtopic DermatitisMixed Topics
Dermatology NewsPatients on methotrexate show T-cell response to Pfizer vaccineJuly 13, 2021COVID-19 UpdatesPsoriasisPsoriatic Arthritis
Dermatology NewsStudy spanning 2 decades offers insights into pediatric psoriasis trendsJuly 8, 2021PediatricsPsoriasisPsoriatic Arthritis
Dermatology NewsNew analysis puts U.S. psoriasis prevalence at 3%July 2, 2021PsoriasisPsoriatic Arthritis
Dermatology NewsMalignancy risk: Secukinumab shows long-term safety for psoriasis, PsA, ankylosing spondylitisJuly 1, 2021PsoriasisAtopic DermatitisPsoriatic ArthritisMixed Topics
Dermatology NewsBiologic treatment mitigates PsA risk in psoriasis patients, study findsJune 24, 2021Psoriatic ArthritisPsoriasis
Dermatology NewsRisankizumab shows efficacy, tolerability in patients with PsAJune 15, 2021Psoriatic Arthritis
Dermatology NewsGRAPPA refines recommendations on psoriatic disease treatmentJune 7, 2021Psoriatic ArthritisPsoriasis
